{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:27:31Z","timestamp":1793924851911,"version":"4.8.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.colsurfb.2026.116223","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:48:49Z","timestamp":1790783329000},"page":"116223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Engineered polymeric nanosponge in-situ gel enables sustained and enhanced nose-to-brain delivery of quetiapine fumarate"],"prefix":"10.1016","volume":"269","author":[{"given":"Priyanshi R.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashka H.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetal P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditixa T.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavin A.","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furqan A.","family":"Maulvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.colsurfb.2026.116223_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/wps.20516","article-title":"What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?","volume":"17","author":"Correll","year":"2018","journal-title":"World Psychiatry"},{"issue":"9","key":"10.1016\/j.colsurfb.2026.116223_bib2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/14737175.2024.2365943","article-title":"Re-evaluating the prognosis of schizophrenia: tackling the issue of inadequate treatment","volume":"24","author":"Agid","year":"2024","journal-title":"Expert. Rev. Neurother."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.116223_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/2045125312474019","article-title":"Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review","volume":"3","author":"Higashi","year":"2013","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.116223_bib4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/med.21252","article-title":"Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery","volume":"33","author":"Vlieghe","year":"2013","journal-title":"Med. Res. Rev."},{"issue":"6","key":"10.1016\/j.colsurfb.2026.116223_bib5","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1021\/acsabm.4c01956","article-title":"Advancements in Using Polymeric Nanoparticles for Blood\u2013Brain Barrier Penetration in Neurological Disorders","volume":"8","author":"Wu","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116223_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-244X-10-26","article-title":"Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone","volume":"10","author":"Johnsen","year":"2010","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116223_bib7","article-title":"Preparation, characterization and evaluation of quetiapine fumarate solid lipid nanoparticles to improve the oral bioavailability","volume":"2013","author":"Narala","year":"2013","journal-title":"J. Pharm."},{"issue":"9","key":"10.1016\/j.colsurfb.2026.116223_bib8","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1111\/cns.14215","article-title":"Cardiac adverse events associated with quetiapine: disproportionality analysis of FDA adverse event reporting system","volume":"29","author":"Shu","year":"2023","journal-title":"CNS Neurosci. & Ther."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116223_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1067\/mcp.2000.107507","article-title":"Quetiapine fumarate overdose: clinical and pharmacokinetic lessons from extreme conditions","volume":"68","author":"Pollak","year":"2000","journal-title":"Clin. Pharmacol. & Ther."},{"issue":"6","key":"10.1016\/j.colsurfb.2026.116223_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/pharmaceutics17060775","article-title":"Intranasal drug delivery technology in the treatment of central nervous system diseases: challenges, advances, and future research directions","volume":"17","author":"Wu","year":"2025","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.colsurfb.2026.116223_bib11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1015830907632","article-title":"The nasal mucociliary clearance: relevance to nasal drug delivery","volume":"8","author":"Schipper","year":"1991","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.colsurfb.2026.116223_bib12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/1567201816666191029122740","article-title":"Drug delivery and targeting to the brain through nasal route: mechanisms, applications and challenges","volume":"16","author":"Kashyap","year":"2019","journal-title":"Curr. Drug. Deliv."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.116223_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10856-022-06652-9","article-title":"The ascension of nanosponges as a drug delivery carrier: preparation, characterization, and applications","volume":"33","author":"Tiwari","year":"2022","journal-title":"Journal Materials Science Materials Medicine"},{"issue":"14","key":"10.1016\/j.colsurfb.2026.116223_bib14","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.3390\/nano12142440","article-title":"Nanosponges for drug delivery and cancer therapy: Recent advances","volume":"12","author":"Iravani","year":"2022","journal-title":"Nanomaterials"},{"issue":"6","key":"10.1016\/j.colsurfb.2026.116223_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/mame.202400356","article-title":"In situ gels for nasal delivery: Formulation, characterization and applications","volume":"310","author":"Qian","year":"2025","journal-title":"Macromol. Mater. Eng."},{"key":"10.1016\/j.colsurfb.2026.116223_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123566","article-title":"A Nanoemulgel for Nose-to-Brain delivery of Quetiapine\u2013QbD-Enabled formulation development & in-vitro characterization","volume":"648","author":"Gadhave","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2026.116223_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijpharm.2019.06.008","article-title":"Plackett-Burman design for screening of critical variables and their effects on the optical transparency and swelling of gatifloxacin-Pluronic-loaded contact lens","volume":"566","author":"Maulvi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2026.116223_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100045","article-title":"QBD approach for the development of hesperetin loaded colloidal nanosponges for sustained delivery: In-vitro, ex-vivo, and in-vivo assessment","volume":"7","author":"Rodrigues","year":"2022","journal-title":"OpenNano"},{"issue":"4","key":"10.1016\/j.colsurfb.2026.116223_bib19","first-page":"158","article-title":"An overview of mucoadhesive thermoreversible nasal gel","volume":"9","author":"Thakur","year":"2021","journal-title":"Asian J. Pharm. Res. Dev."},{"issue":"5","key":"10.1016\/j.colsurfb.2026.116223_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jsps.2021.04.010","article-title":"Formulation and in vitro evaluation of topical nanosponge-based gel containing butenafine for the treatment of fungal skin infection","volume":"29","author":"Ahmed","year":"2021","journal-title":"Saudi Pharm. J."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116223_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12247-024-09912-z","article-title":"Formulation and development of posaconazole loaded controlled release nanosponge topical gel for the treatment of fungal infection","volume":"20","author":"Jani","year":"2025","journal-title":"J. Pharm. Innov."},{"issue":"11","key":"10.1016\/j.colsurfb.2026.116223_bib22","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/17435889.2025.2501518","article-title":"Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method","volume":"20","author":"Liaqat","year":"2025","journal-title":"Nanomedicine"},{"key":"10.1016\/j.colsurfb.2026.116223_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111919","article-title":"Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design","volume":"141","author":"Agrawal","year":"2021","journal-title":"Biomed. & Pharmacother."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.116223_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/02652048.2018.1465138","article-title":"Multiple response optimisation of processing and formulation parameters of pH sensitive sustained release pellets of capecitabine for targeting colon","volume":"35","author":"Pandey","year":"2018","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.colsurfb.2026.116223_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124863","article-title":"Formulation and optimization of transferrin-modified genistein nanocrystals: In vitro anti-cancer assessment and pharmacokinetic evaluation","volume":"667","author":"Iqbal","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116223_bib26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/2230-973X.147233","article-title":"Formulation and evaluation of clindamycin HCL in situ gel for vaginal application","volume":"5","author":"Patel","year":"2015","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.colsurfb.2026.116223_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.22159\/ijap.2019v11i6.35006","article-title":"Formulation and evaluation of gliclazide nanosponges","author":"Solunke","year":"2019","journal-title":"Int. J. Appl. Pharm. 11(6"},{"issue":"3","key":"10.1016\/j.colsurfb.2026.116223_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1208\/s12249-021-01950-x","article-title":"Tailored doxycycline hyclate loaded in situ gel for the treatment of periodontitis: Optimization, in vitro characterization, and antimicrobial studies","volume":"22","author":"Ranch","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"23","key":"10.1016\/j.colsurfb.2026.116223_bib29","doi-asserted-by":"crossref","first-page":"18737","DOI":"10.1039\/C5RA26218F","article-title":"A 3 2 full factorial design for development and characterization of a nanosponge-based intravaginal in situ gelling system for vulvovaginal candidiasis","volume":"6","author":"Osmani","year":"2016","journal-title":"RSC Adv."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.116223_bib30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/ph18030391","article-title":"Development and evaluation of hydrogel-based sulfasalazine-loaded nanosponges for enhanced topical psoriasis therapy","volume":"18","author":"Kumar","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116223_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12247-025-10263-6","article-title":"Development of a Gellan\u2013Carbopol in Situ Gel System for Intranasal Delivery of Artemether-Loaded SLNs: Optimization and Kinetic Evaluation","volume":"21","author":"Bhute","year":"2026","journal-title":"J. Pharm. Innov."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116223_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10971-014-3422-5","article-title":"Formulation and evaluation of thermoreversible, mucoadhesive in situ intranasal gel of rizatriptan benzoate","volume":"72","author":"Kempwade","year":"2014","journal-title":"J. Sol. -gel Sci. Technol."},{"issue":"6","key":"10.1016\/j.colsurfb.2026.116223_bib33","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/10837450.2024.2376102","article-title":"Intranasal delivery of doxepin: enhancing brain targeting efficiency utilizing nanostructured lipid carriers for a biopharmaceutics drug disposition classification system class-I drug","volume":"29","author":"Patel","year":"2024","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.colsurfb.2026.116223_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.113862","article-title":"Clozapine-laden carbon dots delivered to the brain via an intranasal pathway: Synthesis, characterization, ex vivo, and in vivo studies","volume":"237","author":"Patel","year":"2024","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2026.116223_bib35","unstructured":"NorthStar Rx LLC, 2025Accessed 13 September 2026 Quetiapine fumarate tablets: prescribing informationhttps:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=e6e25ef9-2671-489e-8eca-58bedb4f59ab."},{"key":"10.1016\/j.colsurfb.2026.116223_bib36","article-title":"Intranasal nano-delivery systems: emerging strategies for central nervous system disease therapeutics","volume":"588836","author":"Gao","year":"2026","journal-title":"Int. J. Nanomed."},{"issue":"8","key":"10.1016\/j.colsurfb.2026.116223_bib37","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.4314\/tjpr.v17i8.2","article-title":"Development and evaluation of scaffold-based nanosponge formulation for controlled drug delivery of naproxen and ibuprofen","volume":"17","author":"Abbas","year":"2018","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.colsurfb.2026.116223_bib38","article-title":"Development and evaluation of polymeric nanosponge hydrogel for terbinafine hydrochloride: statistical optimization, in vitro and in vivo studies","volume":"12","author":"Ghose","year":"2020","journal-title":"Polym. (Basel"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116223_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15655-z","article-title":"Microsponge based gel as a simple and valuable strategy for formulating and releasing Tazarotene in a controlled manner","volume":"12","author":"Khattab","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.116223_bib40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/ph16040567","article-title":"Optimisation of a greener-approach for the synthesis of cyclodextrin-based nanosponges for the solubility enhancement of domperidone, a BCS class II drug","volume":"16","author":"Vij","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.colsurfb.2026.116223_bib41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1208\/s12249-025-03114-7","article-title":"Ethyl-cellulose nanosponges for topical delivery of simvastatin with preferential skin retention for wound healing in a full-thickness wound rat model","volume":"26","author":"Aboelazayem","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.colsurfb.2026.116223_bib42","series-title":"International symposium on Sustainable Drug Design and Nanoparticle development: Quantum and Computational Perspectives (SDDNDQCP 2025)","first-page":"165","article-title":"Development and Invitro Characterization of Nanosponge Formulation of Lovastatin for Oral Delivery Using a Central Composite Design","author":"Mallam","year":"2025"},{"key":"10.1016\/j.colsurfb.2026.116223_bib43","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.2147\/DDDT.S383051","article-title":"Screening of adapalene microsponges fabrication parameters with insight on the in vitro biological effectiveness","author":"Yehia","year":"2022","journal-title":"Drug. Des. Dev. Ther."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.116223_bib44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/0122103031308362240806113226","article-title":"Revolutionizing Drug Delivery: The Impact of Microsponges in Pharmaceutical Research","volume":"15","author":"Kumar","year":"2025","journal-title":"Drug. Deliv. Lett."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116223_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.25258\/ijddt.12.1.2","article-title":"Preparation of posaconazole nanosponges for improved topical delivery system","volume":"12","author":"Mohammed","year":"2022","journal-title":"Int. J. Drug. Deliv. Technol."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.116223_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.51847\/Q0QRKUV2kQ","article-title":"The effect of formulation and process variables on prepared etoricoxib Nanosponges","volume":"11","author":"Salman","year":"2021","journal-title":"J. Adv. Pharm. Educ. & Res."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.116223_bib47","doi-asserted-by":"crossref","first-page":"279","DOI":"10.69857\/joapr.v13i4.1234","article-title":"Development of abemaciclib-encapsulated nanosponges for breast cancer: optimization, drug release kinetics, and in vitro efficacy","volume":"13","author":"Bolledla","year":"2025","journal-title":"J. Appl. Pharm. Res."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.116223_bib48","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/dmd.108.022814","article-title":"Receptor occupancy and brain free fraction","volume":"37","author":"Watson","year":"2009","journal-title":"Drug. Metab. Dispos."},{"issue":"6","key":"10.1016\/j.colsurfb.2026.116223_bib49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.57.6.553","article-title":"A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy","volume":"57","author":"Kapur","year":"2000","journal-title":"Arch. General. Psychiatry"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526008118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526008118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:54:36Z","timestamp":1793922876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526008118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":49,"alternative-id":["S0927776526008118"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.116223","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered polymeric nanosponge in-situ gel enables sustained and enhanced nose-to-brain delivery of quetiapine fumarate","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.116223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116223"}}